• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制丙酮酸脱氢酶激酶 4 可减轻脓毒症诱导性心肌病中的心肌和线粒体损伤。

Inhibition of Pyruvate Dehydrogenase Kinase 4 Attenuates Myocardial and Mitochondrial Injury in Sepsis-Induced Cardiomyopathy.

机构信息

Department of Pediatric Research Institute, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.

Department of Pediatrics, Women and Children's Hospital of Chongqing Medical University, Chongqing 401147, China.

出版信息

J Infect Dis. 2024 Apr 12;229(4):1178-1188. doi: 10.1093/infdis/jiad365.

DOI:10.1093/infdis/jiad365
PMID:37624974
Abstract

BACKGROUND

Sepsis-induced cardiomyopathy (SIC) is a cardiac dysfunction caused by sepsis, with mitochondrial dysfunction being a critical contributor. Pyruvate dehydrogenase kinase 4 (PDK4) is a kinase of pyruvate dehydrogenase with multifaceted actions in mitochondrial metabolism. However, its role in SIC remains unknown.

METHODS

Serum PDK4 levels were measured and analyzed in 27 children with SIC, 30 children with sepsis, and 29 healthy children. In addition, for mice exhibiting SIC, the effects of PDK4 knockdown or inhibition on the function and structure of the myocardium and mitochondria were assessed.

RESULTS

The findings from the analysis of children with SIC revealed that PDK4 was significantly elevated and correlated with disease severity and organ injury. Nonsurvivors displayed higher serum PDK4 levels than survivors. Furthermore, mice with SIC benefited from PDK4 knockdown or inhibition, showing improved myocardial contractile function, reduced myocardial injury, and decreased mitochondrial structural injury and dysfunction. In addition, inhibition of PDK4 decreased the inhibitory phosphorylation of PDHE1α (pyruvate dehydrogenase complex E1 subunit α) and improved abnormal pyruvate metabolism and mitochondrial dysfunction.

CONCLUSIONS

PDK4 is a potential biomarker for the diagnosis and prognosis of SIC. In experimental SIC, PDK4 promoted mitochondrial dysfunction with increased phosphorylation of PDHE1α and abnormal pyruvate metabolism.

摘要

背景

脓毒症相关性心肌病(SIC)是由脓毒症引起的心脏功能障碍,线粒体功能障碍是其关键致病因素。丙酮酸脱氢酶激酶 4(PDK4)是丙酮酸脱氢酶的一种激酶,在线粒体代谢中具有多方面的作用。然而,其在 SIC 中的作用尚不清楚。

方法

检测并分析 27 例 SIC 患儿、30 例脓毒症患儿和 29 例健康儿童的血清 PDK4 水平。此外,还评估了 PDK4 敲低或抑制对 SIC 小鼠心肌和线粒体功能及结构的影响。

结果

SIC 患儿的分析结果显示,PDK4 水平显著升高,并与疾病严重程度和器官损伤相关。非幸存者的血清 PDK4 水平高于幸存者。此外,SIC 小鼠通过 PDK4 敲低或抑制获益,表现为心肌收缩功能改善、心肌损伤减轻、线粒体结构损伤和功能障碍减少。此外,PDK4 的抑制降低了 PDHE1α(丙酮酸脱氢酶复合物 E1 亚单位α)的抑制性磷酸化,并改善了异常的丙酮酸代谢和线粒体功能障碍。

结论

PDK4 是 SIC 诊断和预后的潜在生物标志物。在实验性 SIC 中,PDK4 通过增加 PDHE1α 的磷酸化和异常的丙酮酸代谢促进线粒体功能障碍。

相似文献

1
Inhibition of Pyruvate Dehydrogenase Kinase 4 Attenuates Myocardial and Mitochondrial Injury in Sepsis-Induced Cardiomyopathy.抑制丙酮酸脱氢酶激酶 4 可减轻脓毒症诱导性心肌病中的心肌和线粒体损伤。
J Infect Dis. 2024 Apr 12;229(4):1178-1188. doi: 10.1093/infdis/jiad365.
2
Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation.抑制丙酮酸脱氢酶激酶 4 通过减少乳酸积累来保护心肌细胞免受脂多糖诱导的线粒体损伤。
Inflammation. 2024 Aug;47(4):1356-1370. doi: 10.1007/s10753-024-01981-z. Epub 2024 Feb 24.
3
Pyruvate-Driven Oxidative Phosphorylation is Downregulated in Sepsis-Induced Cardiomyopathy: A Study of Mitochondrial Proteome.丙酮酸驱动的氧化磷酸化在脓毒症诱导性心肌病中下调:一项线粒体蛋白质组学研究。
Shock. 2022 Apr 1;57(4):553-564. doi: 10.1097/SHK.0000000000001858.
4
Mice deficient in pyruvate dehydrogenase kinase 4 are protected against acetaminophen-induced hepatotoxicity.缺乏丙酮酸脱氢酶激酶 4 的小鼠可预防对乙酰氨基酚引起的肝毒性。
Toxicol Appl Pharmacol. 2020 Jan 15;387:114849. doi: 10.1016/j.taap.2019.114849. Epub 2019 Dec 3.
5
Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response.慢性抑制心脏中的丙酮酸脱氢酶会引发适应性代谢反应。
J Biol Chem. 2011 Apr 1;286(13):11155-62. doi: 10.1074/jbc.M110.217349. Epub 2011 Feb 14.
6
Reducing Oxidative Stress and Inflammation by Pyruvate Dehydrogenase Kinase 4 Inhibition Is Important in Prevention of Renal Ischemia-Reperfusion Injury in Diabetic Mice.抑制丙酮酸脱氢酶激酶 4 减少氧化应激和炎症反应对预防糖尿病小鼠肾缺血再灌注损伤很重要。
Diabetes Metab J. 2024 May;48(3):405-417. doi: 10.4093/dmj.2023.0196. Epub 2024 Feb 1.
7
Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.辅酶 A 介导的丙酮酸脱氢酶激酶 4 降解促进高脂喂养小鼠心脏代谢的灵活性。
J Biol Chem. 2018 May 4;293(18):6915-6924. doi: 10.1074/jbc.RA117.000268. Epub 2018 Mar 14.
8
The Link between Mitochondrial Dysfunction and Sarcopenia: An Update Focusing on the Role of Pyruvate Dehydrogenase Kinase 4.线粒体功能障碍与肌肉减少症之间的联系:以丙酮酸脱氢酶激酶 4 的作用为重点的更新
Diabetes Metab J. 2023 Mar;47(2):153-163. doi: 10.4093/dmj.2022.0305. Epub 2023 Jan 12.
9
FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.FoxO1通过对丙酮酸脱氢酶激酶4表达的转录调控来调节心肌葡萄糖氧化速率。
Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H479-H490. doi: 10.1152/ajpheart.00191.2017. Epub 2017 Jul 7.
10
Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway. adipokine 调节心脏细胞中的丙酮酸脱氢酶通过一个新的 G 蛋白偶联受体 -MAPK-PDK4 信号通路。
Redox Biol. 2018 Sep;18:25-32. doi: 10.1016/j.redox.2018.06.003. Epub 2018 Jun 9.

引用本文的文献

1
Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy.治疗诱导的衰老细胞的持续积累:长期癌症治疗疗效的一个障碍。
Int J Oral Sci. 2025 Aug 1;17(1):59. doi: 10.1038/s41368-025-00380-w.
2
Myocardial pyruvate dehydrogenase kinase 4 drives sex-specific cardiac responses to endotoxemia.心肌丙酮酸脱氢酶激酶4驱动性别特异性心脏对内毒素血症的反应。
JCI Insight. 2025 Jul 8;10(13). doi: 10.1172/jci.insight.191649.
3
Mitochondria at the Heart of Sepsis: Mechanisms, Metabolism, and Sex Differences.
脓毒症核心的线粒体:机制、代谢与性别差异
Int J Mol Sci. 2025 Apr 29;26(9):4211. doi: 10.3390/ijms26094211.
4
Exploring the pathogenesis of sepsis-induced cardiomyopathy: Multilayered mechanisms and clinical responses.探索脓毒症诱导性心肌病的发病机制:多层机制与临床反应
Sci Prog. 2025 Jan-Mar;108(1):368504251329190. doi: 10.1177/00368504251329190. Epub 2025 Mar 20.
5
Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy.综合组学对达格列净在脓毒症诱导的心肌病中作用的见解
Biomolecules. 2025 Feb 14;15(2):286. doi: 10.3390/biom15020286.
6
Sepsis-induced changes in pyruvate metabolism: insights and potential therapeutic approaches.脓毒症诱导的丙酮酸代谢变化:见解与潜在治疗方法。
EMBO Mol Med. 2024 Nov;16(11):2678-2698. doi: 10.1038/s44321-024-00155-6. Epub 2024 Oct 28.
7
Dexmedetomidine Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting MDH2 Lactylation via Regulating Metabolic Reprogramming.右美托咪定通过调节代谢重编程抑制MDH2乳酸化来改善心肌缺血-再灌注损伤。
Adv Sci (Weinh). 2024 Dec;11(48):e2409499. doi: 10.1002/advs.202409499. Epub 2024 Oct 28.
8
ALCAT1-Mediated Pathological Cardiolipin Remodeling and PLSCR3-Mediated Cardiolipin Transferring Contribute to LPS-Induced Myocardial Injury.ALCAT1介导的病理性心磷脂重塑和PLSCR3介导的心磷脂转运促成脂多糖诱导的心肌损伤。
Biomedicines. 2024 Sep 3;12(9):2013. doi: 10.3390/biomedicines12092013.
9
Dichloroacetate Prevents Sepsis Associated Encephalopathy by Inhibiting Microglia Pyroptosis through PDK4/NLRP3.二氯乙酸通过PDK4/NLRP3抑制小胶质细胞焦亡来预防脓毒症相关性脑病。
Inflammation. 2024 Aug 23. doi: 10.1007/s10753-024-02105-3.